Vor Bio Appoints Industry Veteran Osovsky as General Counsel

Vor BioPharma Inc., a clinical-stage biotechnology company focused on autoimmune diseases, has appointed Adi Osovsky as general counsel, it said Tuesday.

Osovsky brings 17 years of corporate counsel and law firm experience in the biotechnology and pharmaceutical sectors. She previously held senior legal roles at iTeos Therapeutics and Sarepta Therapeutics, supporting corporate transactions, securities matters, and governance. She holds an LL.B. from Tel Aviv University and both an LL.M. and an S.J.D. in securities regulation from Harvard Law School. She is a former associate in Sullivan & Worcester LLP’s capital markets practice.

Osovsky will provide legal counsel and guidance to ...